Stock market analysts have maintained 'buy' rating on Ankur Drugs & Pharma Ltd with an intraday target of Rs 214.

According to them, interested traders can purchase the stock above Rs 210 with a strict stop loss of Rs 205.

If the stock markets remain on the positive path then the stock price will hit a target above Rs 220.

Shares of the company, on Tuesday (Dec 22), closed at Rs 209.20 on the Bombay Stock Exchange (BSE). The share price has seen a 52-week high of Rs 249.05 and a low of Rs 51.00 on BSE.

Ankur Drugs & Pharma Ltd's major activity is to make and sell pharmaceutic formulations in the form of pills, capsules, liquid orals and dry syrups.

Ankur Drugs & Pharma is going to produce injectables, effervescent tabs/Powders, water for shot, eye & ear drops and balms.